Last reviewed · How we verify
NCT07473765: VR ALS
Virtual Reality for Anxiety Management in Persons With Amyotrophic Lateral Sclerosis
NA trial testing Virtual Reality Guided Breathing Exercise in ALS (Amyotrophic Lateral Sclerosis) in 60 participants. Not yet recruiting.
31 March 2027
Quick facts
| Lead sponsor | Horizon Health Network |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 60 |
| Start date | 1 April 2026 |
| Primary completion | 31 March 2027 |
| Estimated completion | 30 June 2027 |
Drugs / interventions tested
- Virtual Reality Guided Breathing Exercise
Conditions studied
- ALS (Amyotrophic Lateral Sclerosis) — all drugs for ALS (Amyotrophic Lateral Sclerosis) →
Sponsor
Horizon Health Network
Who can join
Eligibility, any sex, with ALS (Amyotrophic Lateral Sclerosis). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Virtual Reality (VR) is gaining traction as a new and innovative leisure to augment healthcare services. Several benefits of the leisure experience, such as distraction and full sensory immersion, have demonstrated a potential to significantly impact the field of healthcare through pain reduction, anxiety reduction, and is seen as an innovative approach to motor learning. Persons with ALS (pwALS) have a high prevalence of anxiety over the course of their illness, which has a negative impact on their quality of life, and the quality of life of those closest to them. The use of VR for anxiety management and subsequent quality of life improvement has yet to be explored in the ALS population. For individuals with ALS, VR can be both (1) an escape from the reality of living day to day with a progressive fatal diagnosis; and (2) the opportunity to potentially improve anxiety, both of which are linked to the quality of life of individuals living with ALS. Our hypothesis is that a simple and accessible home VR-guided relaxation exercise program can improve subjective anxiety symptoms in a person living with ALS and subsequently improve quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07473765
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for ALS (Amyotrophic Lateral Sclerosis)
Currently open trials in the same condition.
- NCT07067229 — Non-invasive Brain Stimulation and Exercise Intervention for Patients With Motor Neuron Disease · NA · recruiting
- NCT07006571 — At-home Treatment With Cortico-spinal tDCS for Amyotrophic Lateral Sclerosis · NA · recruiting
- NCT07175935 — Amyotrophic Lateral Sclerosis Registry in Thailand · recruiting
- NCT07235111 — Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases · recruiting
- NCT06810219 — Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS · NA · recruiting
Other Horizon Health Network trials
Trials by the same sponsor.
- NCT06107699 — The CHARM Study-Coordinating Transitions from Hospital for Older Adults with Fractures · NA · completed
- NCT05429879 — The Impact of Music on Pain and Anxiety During Flexible Cystoscopies · NA · unknown
- NCT03035656 — Effects of Intra-Operative Ropivaciane Epidural Injection on Post-Operative Outcomes Following Elective Lumbar Fusion · Phase 4 · unknown
- NCT03421132 — Multiple Myeloma Molecular Monitoring Study · active not recruiting
- NCT02870465 — Hand K-wire Infections in Operating Room Versus Ambulatory Setting · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07473765 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Horizon Health Network
- Last refreshed: 16 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07473765.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing